Results 281 to 290 of about 136,147 (343)

Non-invasive assessment of intracranial compliance in idiopathic intracranial hypertension: an MRI-ICP study. [PDF]

Eye (Lond)
Sassani M, Mitchell JL, Yiangou A, Davies N, Sawlani V, Mollan SP, Wagshul ME, Sinclair AJ.   +7 more
europepmc   +1 more source

The Role of Proton Magnetic Resonance Spectroscopy in Neonatal and Fetal Brain Research

Journal of Magnetic Resonance Imaging, Volume 61, Issue 6, Page 2404-2424, June 2025.
The biochemical composition and structure of the brain are in a rapid change during the exuberant stage of fetal and neonatal development. 1H‐MRS is a noninvasive tool that can evaluate brain metabolites in healthy fetuses and infants as well as those with neurological diseases.
Steve C.N. Hui, Nickie Andescavage, Catherine Limperopoulos   +2 more
wiley   +1 more source

Aminoguanidine Protects Against Intracranial Hypertension and Cerebral Ischemic Injury in Experimental Heatstroke

, 2004
Ching‐Ping Chang, Chin-Cheng Lee, Sheng-Hsien Chen, Mao‐Tsun Lin   +3 more
openalex   +2 more sources

Idiopathic intracranial hypertension presenting as bilateral palpebral venous engorgement. [PDF]

Am J Ophthalmol Case Rep
Butterfield SD, Silkiss RZ.
europepmc   +1 more source

Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis

Muscle &Nerve, Volume 71, Issue 6, Page 1006-1015, June 2025.
ABSTRACT Introduction/Aims Tofersen is approved for the treatment of amyotrophic lateral sclerosis (ALS) due to superoxide dismutase 1 mutations (SOD1‐ALS). Here we report serious neurologic adverse events (AEs) that occurred in the tofersen clinical trials in people with SOD1‐ALS.
Alexandra Lovett, Sowmya Chary, Suma Babu, Gaëlle Bruneteau, Jonathan D. Glass, Merete Karlsborg, Shafeeq Ladha, Keith Mayl, Christopher McDermott, Robert C. Bucelli, Adriano Chiò, Toby A. Ferguson, Thos Cochrane, Stephanie Fradette, Karen Smirnakis, Jennifer Inra, Sohail Malek, Laura Fanning   +17 more
wiley   +1 more source

Examining the Time to Diagnosis in Idiopathic Intracranial Hypertension Presentations in a Specialist Eye Emergency Department. [PDF]

Cureus
Cope E, Crock C, Fahrer C.
europepmc   +1 more source

Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders

Acta Psychiatrica Scandinavica, Volume 151, Issue 6, Page 689-697, June 2025.
ABSTRACT Introduction Patients with mood disorders, especially, major depressive disorder (MDD) and bipolar disorder (BD), are at heightened risk of relapse and psychiatric rehospitalizations. Therefore, there is an urgent need to identify modifiable biomarkers to inform personalized and intensified prevention strategies for those at the greatest risk ...
Kamilla W. Miskowiak, Julian Macoveanu, Brice Ozenne, Emily E. Beaman, Vibeke H. Dam, Patrick M. Fisher, Gitte M. Knudsen, Lars V. Kessing, Martin B. Jørgensen, Vibe G. Frokjaer, Anjali Sankar   +10 more
wiley   +1 more source

Unusual association of cervical arachnoid cyst and idiopathic intracranial hypertension. [PDF]

Neurosciences (Riyadh)
Alokayli SH, Maghrabi SA, Almotairi FS, Elwatidy SM.   +3 more
europepmc   +1 more source

Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50%

Cancer, Volume 131, Issue 10, 15 May 2025.
Abstract Background In the phase 3 EMPOWER‐Lung 1 study, first‐line cemiplimab monotherapy provided significant survival benefit versus chemotherapy in patients with advanced non–small cell lung cancer (NSCLC) with programmed cell death‐ligand 1 (PD‐L1) ≥50%.
Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, Mahmut Gümüş, Igor Bondarenko, Miranda Gogishvili, Haci M. Turk, Irfan Cicin, Dmitry Bentsion, Oleg Gladkov, Virote Sriuranpong, Ruben G. W. Quek, Debra A. G. McIntyre, Xuanyao He, Jennifer McGinniss, Frank Seebach, Giuseppe Gullo, Petra Rietschel, Jean‐Francois Pouliot   +18 more
wiley   +1 more source

A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension. [PDF]

Headache
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Thaller M, Grech O, Alimajstorovic Z, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ.   +10 more
europepmc   +1 more source